Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - CASH & EQUIVALENTS
Cash & Equivalents ANAB - AnaptysBio, Inc.
36 M
LAST VALUE
-73.06%
2 YEAR CAGR
-20.55%
5 YEAR CAGR
29.04%
10 YEAR CAGR